Literature DB >> 2833536

Localization and characterization of angiotensin II receptor binding and angiotensin converting enzyme in the human medulla oblongata.

A M Allen1, S Y Chai, J Clevers, M J McKinley, G Paxinos, F A Mendelsohn.   

Abstract

Angiotensin II receptor and angiotensin converting enzyme distributions in the human medulla oblongata were localised by quantitative in vitro autoradiography. Angiotensin II receptors were labelled with the antagonist analogue 125I-[Sar1, Ile8] AII while angiotensin converting enzyme was labelled with 125I-351A, a derivative of the specific converting enzyme inhibitor, lisinopril. Angiotensin II receptor binding and angiotensin converting enzyme are present in high concentrations in the nucleus of the solitary tract, the dorsal motor nucleus of vagus, the rostral and caudal ventrolateral reticular nucleus, and in a band connecting the dorsal and ventral regions. In the rostral and caudal ventrolateral reticular nucleus, angiotensin II receptors are distributed in a punctate pattern that registers with neuronal cell bodies. The distribution and density of these cell bodies closely resemble those of catecholamine-containing neurones mapped by others. In view of the known interactions of angiotensin II with both central and peripheral catecholamine-containing neurons of laboratory animals, the current anatomical findings suggest similar interactions between these neuroactive compounds in the human central nervous system. The presence of angiotensin II receptors and angiotensin converting enzyme in the nucleus of the solitary tract, dorsal motor nucleus of vagus, and rostral and caudal ventrolateral reticular nucleus demonstrates sites for central angiotensin II to exert its known actions on vasopressin release and autonomic functions including blood pressure control. These data also suggest a possible interaction between angiotensin II and central catecholeminergic systems.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833536     DOI: 10.1002/cne.902690209

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  9 in total

Review 1.  Paraventricular nucleus, stress response, and cardiovascular disease.

Authors:  Eduardo E Benarroch
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

Review 2.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

3.  Selective C1 Lesioning Slightly Decreases Angiotensin II Type I Receptor Expression in the Rat Rostral Ventrolateral Medulla (RVLM).

Authors:  Erick A Bourassa; Kristen A Stedenfeld; Alan F Sved; Robert C Speth
Journal:  Neurochem Res       Date:  2015-07-03       Impact factor: 3.996

4.  Association between resting-state brain functional connectivity and muscle sympathetic burst incidence.

Authors:  Keri S Taylor; Aaron Kucyi; Philip J Millar; Hisayoshi Murai; Derek S Kimmerly; Beverley L Morris; T Douglas Bradley; John S Floras
Journal:  J Neurophysiol       Date:  2015-11-04       Impact factor: 2.714

5.  Resting regional brain activity and connectivity vary with resting blood pressure but not muscle sympathetic nerve activity in normotensive humans: An exploratory study.

Authors:  Sophie Kobuch; Vaughan G Macefield; Luke A Henderson
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-05       Impact factor: 6.200

6.  Angiotensin AT1 receptor-mediated excitation of rat carotid body chemoreceptor afferent activity.

Authors:  A M Allen
Journal:  J Physiol       Date:  1998-08-01       Impact factor: 5.182

Review 7.  Neurology and the COVID-19 Pandemic: Gathering Data for an Informed Response.

Authors:  Brigit High; Alison M Hixon; Kenneth L Tyler; Amanda L Piquet; Victoria S Pelak
Journal:  Neurol Clin Pract       Date:  2021-04

8.  The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.

Authors:  Rhiannon Coulson; Seng H Liew; Angela A Connelly; Nicholas S Yee; Siddhartha Deb; Beena Kumar; Ana C Vargas; Sandra A O'Toole; Adam C Parslow; Ashleigh Poh; Tracy Putoczki; Riley J Morrow; Mariah Alorro; Kyren A Lazarus; Evie F W Yeap; Kelly L Walton; Craig A Harrison; Natalie J Hannan; Amee J George; Colin D Clyne; Matthias Ernst; Andrew M Allen; Ashwini L Chand
Journal:  Oncotarget       Date:  2017-03-21

Review 9.  Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease.

Authors:  Erin F Balcom; Avindra Nath; Christopher Power
Journal:  Brain       Date:  2021-12-31       Impact factor: 13.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.